Insider · CIK 0002022163
Simona Skerjanec
Files at IMUX (IMMUNIC, INC.), RNA (Avidity Biosciences, Inc.), RNA (Atrium Therapeutics, Inc.). First filing -, latest -.
Simona Skerjanec files SEC Form 4 as director at IMUX (IMMUNIC, INC.), and also at RNA (Avidity Biosciences, Inc.), RNA (Atrium Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Simona Skerjanec has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | RNA Atrium Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Mar 2, 2026 |
| Feb 27, 2026 | RNA Avidity Biosciences, Inc. | DDisposition to issuer Common Stock | -6,692 | - | - | 0 | Feb 27, 2026 |
| Feb 27, 2026 | RNA Avidity Biosciences, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,034 | - | - | 0 | Feb 27, 2026 |
| Feb 27, 2026 | RNA Avidity Biosciences, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -42,308 | - | - | 0 | Feb 27, 2026 |
| Jun 10, 2025 | RNA Avidity Biosciences, Inc. | AGrant or award Common Stock | +6,692 | $0.00 | $0 | 6,692 | Jun 12, 2025 |
| Jun 10, 2025 | RNA Avidity Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,034 | $0.00 | $0 | 10,034 | Jun 12, 2025 |
| Jun 5, 2025 | IMUX IMMUNIC, INC. | AGrant or award Stock Optionderivative | +150,000 | $0.00 | $0 | 150,000 | Jun 9, 2025 |
Questions about Simona Skerjanec
Answered from the filings on this page, as of the latest one.
Is Simona Skerjanec buying or selling?
Simona Skerjanec has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Simona Skerjanec's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Simona Skerjanec has 0.
Where does Simona Skerjanec file Form 4?
Simona Skerjanec has filed Form 4 at IMUX (IMMUNIC, INC.); RNA (Avidity Biosciences, Inc.); RNA (Atrium Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.